NEU 📈 Neuca S.A. - Overview

Exchange: WAR • Country: Poland • Currency: PLN • Type: Common Stock • ISIN: PLTRFRM00018

NEU: Pharmaceuticals, Dietary Supplements, Medical Devices, Dermocosmetics

NEUCA S.A. engages in the wholesale distribution of pharmaceuticals in Poland. It operates through Wholesale Distribution of Medicines, Manufacture of Pharmaceuticals, Medical Operator, Clinical Trials, and Insurance Activities segments. The company owns and produces Rx, OTC medicines, dietary supplements, medical devices, dermocosmetics, hygiene products, personal protective equipment, as well as diagnostic and dressing materials under the Swiat Zdrowia, APTEO, GENOPTIM, CERA+ Solutions, and Kic Kic brand names to pharmacists, medical doctors, and patients. It provides medical care services, including prevention, diagnostics, treatment, and complementary services; and financing services, such as insurance, subscriptions, occupational medicine, preventive and medicine programmes, FFS, NFZ, public, private, and corporate payer services. In addition, the company offers TPA services, remote consultations, stationary visits, diagnostic tests, and occupational medicine services; operates a medical helpline and medical facilities; and offers medicine through apteline.pl, an e-commerce medical ordering site. Further, it engages in running clinical trials in the field of outsourcing clinical research and conducting clinical research centres; provision of insurance activities, including health insurance products. It also provides advertising and marketing services to pharmaceutical market entities; and logistics services for pharmaceutical manufacturers. The company was formerly known as Torfarm SA and changed its name to NEUCA S.A. in April 2010. NEUCA S.A. was founded in 1990 and is based in Torun, Poland. Web URL: https://www.neuca.pl

Additional Sources for NEU Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

NEU Stock Overview

Market Cap in USD 887m
Sector Healthcare
Industry Medical Distribution
GiC Sub-Industry Drug Retail
IPO / Inception

NEU Stock Ratings

Growth 5y 58.9%
Fundamental 41.7%
Dividend 64.8%
Rel. Strength Industry -58.7
Analysts -
Fair Price Momentum 919.68 PLN
Fair Price DCF 1275.07 PLN

NEU Dividends

Dividend Yield 12m 1.62%
Yield on Cost 5y 4.08%
Annual Growth 5y 11.93%
Payout Consistency 99.8%

NEU Growth Ratios

Growth Correlation 3m 6.2%
Growth Correlation 12m -41.1%
Growth Correlation 5y 66.7%
CAGR 5y 19.81%
CAGR/Mean DD 5y 1.53
Sharpe Ratio 12m 0.01
Alpha -9.92
Beta 0.30
Volatility 25.53%
Current Volume 1.9k
Average Volume 20d 1.4k
What is the price of NEU stocks?
As of December 22, 2024, the stock is trading at PLN 877.00 with a total of 1,878 shares traded.
Over the past week, the price has changed by +0.45%, over one month by +18.73%, over three months by +7.97% and over the past year by +5.60%.
Is Neuca S.A. a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, Neuca S.A. (WAR:NEU) is currently (December 2024) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 41.69 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of NEU as of December 2024 is 919.68. This means that NEU is currently overvalued and has a potential downside of 4.87%.
Is NEU a buy, sell or hold?
Neuca S.A. has no consensus analysts rating.
What are the forecast for NEU stock price target?
According to ValueRays Forecast Model, NEU Neuca S.A. will be worth about 1000.5 in December 2025. The stock is currently trading at 877.00. This means that the stock has a potential upside of +14.08%.
Issuer Forecast Upside
Wallstreet Target Price 1008.8 15%
Analysts Target Price - -
ValueRay Target Price 1000.5 14.1%